Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (381-390 of 484) with videos related to

Pageof 49
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
Journal of Scleroderma and Related Disorders|May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosisDinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Arthritis and Rheumatism|March 3, 2007
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosisFrancesco Zulian, Patricia Woo, Balu H Athreya, et al.
Respiratory Research|December 2, 2004
Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblastsElisabetta A Renzoni, David J Abraham, Sarah Howat, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2023
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Christopher P Denton, Daniel E Furst, et al.
The New England Journal of Medicine|September 21, 2007
A polymorphism in the CTGF promoter region associated with systemic sclerosisCarmen Fonseca, Gisela E Lindahl, Markella Ponticos, et al.
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Pageof 49

Showing results (381-390 of 484) with videos related to

Sort By:
Pageof 49
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
Journal of Scleroderma and Related Disorders|May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosisDinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Arthritis and Rheumatism|March 3, 2007
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosisFrancesco Zulian, Patricia Woo, Balu H Athreya, et al.
Respiratory Research|December 2, 2004
Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblastsElisabetta A Renzoni, David J Abraham, Sarah Howat, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2023
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Christopher P Denton, Daniel E Furst, et al.
The New England Journal of Medicine|September 21, 2007
A polymorphism in the CTGF promoter region associated with systemic sclerosisCarmen Fonseca, Gisela E Lindahl, Markella Ponticos, et al.
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Pageof 49